Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Revolutionary technology could help identify more effective cancer drug combinations

Revolutionary technology could help identify more effective cancer drug combinations

Singapore researchers find common therapeutic vulnerability for a deadly blood cancer

Singapore researchers find common therapeutic vulnerability for a deadly blood cancer

Immunotherapy combination can shrink viral reservoir in HIV model

Immunotherapy combination can shrink viral reservoir in HIV model

Blood stem cells conserve epigenetic memory of previous infections to boost immunity

Blood stem cells conserve epigenetic memory of previous infections to boost immunity

Scientists receive €2.45 million funding for leukemia research

Scientists receive €2.45 million funding for leukemia research

Genetic test could help doctors to identify patients with ultra high risk multiple myeloma

Genetic test could help doctors to identify patients with ultra high risk multiple myeloma

The second person cured from HIV goes public

The second person cured from HIV goes public

New 'Immuno-Engineering to Improve Immunotherapy' Center formed to advance cancer therapy

New 'Immuno-Engineering to Improve Immunotherapy' Center formed to advance cancer therapy

Newly identified genetic signatures in common pediatric cancer pave way for precision medicine

Newly identified genetic signatures in common pediatric cancer pave way for precision medicine

Subpopulations of leukemic cells present at diagnosis can cause relapse in children with ALL

Subpopulations of leukemic cells present at diagnosis can cause relapse in children with ALL

Study: Five-year survival rate for adolescents and young adults with cancer has improved

Study: Five-year survival rate for adolescents and young adults with cancer has improved

Treatments for rare diseases affecting children are increasing, study suggests

Treatments for rare diseases affecting children are increasing, study suggests

Study finds improvements in survival rates for all cancers in young adults

Study finds improvements in survival rates for all cancers in young adults

Michael Hall named winner of 2020 Sjöberg Prize

Michael Hall named winner of 2020 Sjöberg Prize

Scientists discover three genes linked to idiopathic pulmonary fibrosis

Scientists discover three genes linked to idiopathic pulmonary fibrosis

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

Stem cell discovery could open the door to new approach for bone marrow transplantation

Stem cell discovery could open the door to new approach for bone marrow transplantation

Harmful levels of metal linked to DNA damage found in the urine of e-cigarette users

Harmful levels of metal linked to DNA damage found in the urine of e-cigarette users

Researchers reveal new vulnerability in MYC-driven lymphomas

Researchers reveal new vulnerability in MYC-driven lymphomas

Single gene cluster loss promotes initiation and progression of multiple myeloma in mice

Single gene cluster loss promotes initiation and progression of multiple myeloma in mice

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.